» Human Factor VII congenital Deficient Plasma

HEMOSTASIS COAGULATION RESEARCH DEFICIENT PLASMAS CONGENITAL DEFICIENT PLASMAS (KITS)

Human Factor VII congenital Deficient Plasma

Fresh frozen plasmas

Plasma from a single human donor with congenital Factor VII deficiency.
Native coagulation factor deficient plasmas are fresh frozen plasmas obtained exclusively from donors with severe congenital clotting factor deficiency.

Ces plasmas déficients natifs en facteur de la coagulation sont recommandés pour l’évaluation de l’activité des facteurs de la coagulation par la méthode de dosage du taux de prothrombine (TP) ou temps de céphaline activé (TCA) nécessitant l’emploi d’un plasma dépourvu en facteur (< 1 %) en hémostase.

Reference	7-0700
Presentation	Kit
Format	5 x 1.0 mL
Quote

Price list, safety data sheets and notices are accessible to our registered customers.

Reference	Presentation	Format	Quote	Product sheet
7-0700	Kit	5 x 1.0 mL

Price list, safety data sheets and notices are accessible to our registered customers.

Factor VII (FVII) is a glycoprotein synthesized by the liver, vitamin k dependent. When tissue factor (TF) appears on the surface of damaged, abnormal or activated vascular endothelium, FVIIa associates with it, initiating the extrinsic pathway of coagulation.
The FT-FVIIa complex activates the FX in FXa and the FIX in FIXa.

- Frozen plasmas, certified to have less than 1% for the deficient factor considered, both for the antigenic assay and for functional hemostasis.
- This plasma is stable, if stored at -40 to -80 °C, until the end of the month of the expiration date indicated on the package.

- None of these plasmas contain inhibitors.
- No additives or preservatives.
- Freezing the plasmas makes it possible to keep the matrix perfectly intact and to avoid reconstitution.
- Packaging in plastic cryotubes suitable for all STA-R type micro-cup supports.

- 5 cryotubes x 1 mL of frozen plasma

Human Factor IX congenital Deficient Plasma
Human Factor V congenital Deficient Plasma
Human Factor VIII congenital Deficient Plasma
Human Factor VIII congenital Deficient Plasma with inhibitor
Human Factor X congenital Deficient Plasma
Human Factor XI congenital Deficient Plasma
Human Factor XII congenital Deficient Plasma
Human Factor XIII congenital Deficient Plasma
Human Prekallikrein congenital Deficient Plasma

	These kits are manufactured in accordance with the 98/79 EC directive for in vitro diagnostic devices. Only CE marked products can be used for diagnostic applications in Europe.
	These kits are intended for in vitro diagnostic use.
	These kits are for research use only and are not intended to be used for diagnostic procedures.
	Federal Drug Administration, FDA validates diagnostic kits for in vitro diagnostic use in the United States.
	Biological risk products.
	Storage between 2 and 8 ° C.
	Reactive in liquid form.
	Reactive in lyophilized form.
	Reactive in frozen form.
	Stability after opening at 2-8 ° C.
	Products that can be refrozen.
	Stability 12 months after refreezing at -20 ° C.
	Manufacturer.
	Importer
	Distributor.

HEMOSTASIS COAGULATION RESEARCH DEFICIENT PLASMAS CONGENITAL DEFICIENT PLASMAS (KITS)